The Open UniversitySkip to content
 

Huntington's Disease Research

The Synaptic Basis of Learning and Memory in Health and Disease

One of the greatest challenges facing medical science is to defeat neurodegenerative brain disease. As our population ages, more of us will be afflicted by devastating brain disorders such as Alzheimer's disease, Parkinson's disease and senile dementia - neurodegenerative conditions that rob us of the ability to think, to learn and to remember. Until very recently, these diseases remained intractable to modern science. However, rapid advances in molecular genetics and the advent of transgenic models for some of these diseases, has now made it is now possible, for the first time, to study the pathogenic process and examine how it affects the physiology of the brain, especially those mechanisms involved in learning and memory. It is hoped that studies of this type will aid the development of new and effective treatments in the fight against brain disease.

The laboratory is interested in how brain disease affects communication between brain cells. In our brains, cells transfer information at specialized structures called synapses. These convert electrical signals into chemical ones that diffuse to the receiving cell where they initiate new electrical signals. Changes in the efficiency of synaptic communication and the connectivity between brain cells are believed to play a vital role in the encoding and storage of information. The most widely studied form of synaptic plasticity thought to be important for learning is that of long-term potentiation (LTP; see ref 1). LTP is an activity-dependent and a lasting increase in the efficiency of transmission at brain synapses; an example is shown on the left. Post-mortern human brain Currently, we are investigating synaptic function in Huntington's disease - a genetic disorder that affects 1-3 people per 20,000 of population.The image shows two sections of human brain, one taken from a normal patient who died of natural causes and one from a patient who died of Huntington's disease. Notice how the Huntington's diseased brain has undergone massive neurodegeneration.

Currently, there is no cure for this devastating condition. Our studies and others show that synaptic plasticity and some aspects of cell function are abnormal in early-stage Huntington's disease (refs 2,3,4). These observations are significant as they occur long before the brain starts to degenerate. If we can identify the cause(s) of these changes we will be able to design new therapies to treat this disease. To this end we are using pharmacological tools to isolate the defective proteins and molecules that give rise to abnormal synaptic plasticity and cell function in Huntington's disease. Inclusions within nuclei of hippocampal neurones.

One possible clue to the pathogenic process involved in Huntington's disease is that, in common with other neurodegenerative diseases, there is an abnormal accumulation of aberrant proteins. In Huntington's disease, these proteins aggregate to form insoluble inclusions that often precipitate within the cell nucleus, disrupting the normal processes of the cell (figure shows inclusions within nuclei of hippocampal neurones; adapted from ref 2). We are examining the relationship between the formation of inclusions and the impairment of synaptic function. In addition, we are also investigating the action of drugs that prevent inclusion formation on synaptic plasticity and cell function.

References

  1. Bliss TVP and Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
  2. Murphy KPSJ et al. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. Journal of Neuroscience 20: 5115-5123.
  3. Hodgson JG et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.  Neuron 23: 181-192.
  4. Usdin MT et al. (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation.  Human Molecular Genetics 8: 839-846.
EPSP


Post-mortem Human Brain



panel-c
© The Open University   +44 (0)845 300 60 90   Email us